Vanda Repiská

Chromosome Abnormalities and Genetic Counseling

Engineering precision nanoparticles for drug delivery

Mechanisms of NOD-like Receptor-Associated Inflammasome Activation

Gestational trophoblastic disease

Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole

Human Mesenchymal Stem Cells as a Carrier for a Cell-Mediated Drug Delivery

The Therapeutic Potential of Modifying Inflammasomes and NOD-Like Receptors

Health Supervision for Children With Down Syndrome

Inflammasomes: mechanism of action, role in disease, and therapeutics

The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome–mediated inflammatory disease

Precision Cancer Nanotherapy: Evolving Role of Multifunctional Nanoparticles for Cancer Active Targeting

Lipid-Based Nanovesicular Drug Delivery Systems

Interferon-Stimulated Genes: A Complex Web of Host Defenses

Identification of 13 novel NLRP7 mutations in 20 families with recurrent hydatidiform mole; missense mutations cluster in the leucine-rich region

Human mesenchymal stem cell-derived iron oxide exosomes allow targeted ablation of tumor cells via magnetic hyperthermia

Prodrug suicide gene therapy for cancer targeted intracellular by mesenchymal stem cell exosomes